• SENSEX 80,995.43
    395.52 (+0.49%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Axis Bank
    1,070.00 1,281.75(%)
  • KIOCL
    395.00 461.35(%)
  • Netweb Technol.
    2,340.00 3,060.00(%)
  • G M D C
    423.95 472.40(%)
  • Delhivery
    457.95 449.30(%)
  • Multi Comm. Exc.
    8,058.45 9,110.00(%)
  • Vimta Labs
    646.40 235.00(%)
  • Jayaswal Neco
    51.40 55.34(%)
  • Suzlon Energy
    65.00 46.00(%)
  • A B B
    5,015.45 4,590.05(%)
  • JSW Steel
    1,058.90 1,074.15(%)
  • HDFC Bank
    1,997.50 1,593.20(%)
  • Hero Motocorp
    4,469.75 6,245.00(%)
  • Yatharth Hospit.
    657.00 692.85(%)
  • Tata Power Co.
    376.50 326.25(%)
  • Tata Motors
    656.70 1,176.30(%)
  • Sarda Energy
    527.10 565.55(%)
  • TCS
    3,039.00 4,585.90(%)
  • Swiggy
    402.50 617.00(%)
  • PNB Housing
    772.00 746.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Wockhardt Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt
  • BSE Code : 8021.0
  • ISIN : INE049B01025
1,612.40 -55 (-3.30%)
  • As on 04 Aug 2025 (EOD)

  • Today’s Low

    1,600.00

  • Today’s High

    1,676.70

  • Open

    1,667.00

  • Perv Close

    1,667.50

  • 52W Low

    840.00

  • 52W High

    1,868.80

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    26,199.17

  • Div & Yield %

    0.00

  • Book Value(₹)

    170.06

  • Debt-Equity Ratio

    -3.30

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.68

  • Mar.Cap (₹Cr.)

    26,199.17

  • RONW (%)

    -12.34

  • ROCE (%)

    -0.86

Score Board

  • Equity (₹ in Cr.)

    81.24

  • BV (₹)

    170.10

  • Sales( ₹ in Cr.)

    1,402.00

  • NP (in Cr.)

    -12.00

  • NP Var(%)

    97.0

  • Div%

    0.0

  • CPS (₹)

    9.60

  • EPS (₹)

    -0.70

  • Traded Value (₹ in Lakhs)

    26,166.68

  • 52 Week High

    1,868.80

  • 52 Week Low

    840.00

  • Price BSE

    1610.0

  • Price NSE

    1,612.00

  • Market Capital( in Cr.)

    26,166.68

  • P/C Ratio

    167.70

  • P/E Ratio

    -2,180.00

  • Price Vs.BV

    -0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,402.00 1,154.00 1,072.00 1,372.00 987.00 890.06
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,402.00 1,154.00 1,072.00 1,372.00 987.00 890.06
Other Income 55.00 41.00 67.00 38.00 1,026.00 137.58
Stock Adjustments 46.00 -14.00 -30.00 -2.00 2.00 8.61
Total Income 1,503.00 1,181.00 1,109.00 1,408.00 2,015.00 1,036.25
EXPENDITURE :            
Raw Materials 482.00 447.00 371.00 474.00 418.00 321.90
Power and Fuel Cost 75.00 68.00 54.00 62.00 55.00 61.02
Employee Cost 262.00 247.00 240.00 261.00 293.00 325.46
Other Manufacturing Expenses 71.00 71.00 60.00 94.00 86.00 54.39
Selling and Administration Expenses 180.00 179.00 178.00 181.00 166.00 180.29
Miscellaneous Expenses 78.00 178.00 304.00 76.00 251.00 88.75
Employee Benefit Expenses 262.00 247.00 240.00 261.00 293.00 325.46
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,148.00 1,190.00 1,207.00 1,148.00 1,269.00 1,031.81
Operating Profit 355.00 -9.00 -98.00 260.00 746.00 4.44
Interest 199.00 237.00 229.00 273.00 200.00 220.17
Gross Profit 156.00 -246.00 -327.00 -13.00 546.00 -215.73
Depreciation 168.00 176.00 186.00 171.00 184.00 173.39
Profit Before Tax -12.00 -422.00 -513.00 -184.00 362.00 -389.12
Current Tax 0.00 0.00 0.00 5.00 -136.00 -47.11
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 -47.00 -49.00 -95.00 -110.89
Reported Net Profit -12.00 -422.00 -466.00 -140.00 593.00 -231.12
Extraordinary Items 0.00 -14.00 -235.00 0.00 -142.00 0.00
Adjusted Net Profit -12.00 -408.00 -231.00 -140.00 735.00 -231.12
Adjustment below Net Profit 0.00 0.00 4.00 -1.00 0.00 3.81
P & L Balance brought forward -890.00 -468.00 -3.00 138.00 -125.00 103.08
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 330.00 0.00
P & L Balance carried down -902.00 -890.00 -465.00 -3.00 138.00 -124.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -0.74 -27.40 -32.36 -9.72 53.91 -20.87
Earnings Per Share(Adj)-Unit Curr -0.74 -27.40 -32.36 -9.72 49.68 -19.23
Book Value 170.56 116.62 121.74 153.61 146.00 89.82
Book Value(Adj)-Unit Curr 170.56 116.62 121.74 153.61 134.54 82.77

Shareholding Pattern

  • Promoter Group

    49.09%

  • Public Share Holding

    50.91%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 78,578,797 48.36 78,578,797 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,180,051 0.73 1,180,051 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 79,758,848 49.09 79,758,848 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 32,248 0.02 32,248 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 630 0.00 130 4
Foreign Bank 10,200 0.01 10,200 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 11,833,367 7.28 11,832,167 137
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 740,433 0.46 739,033 4
Mutual Funds / UTI 13,038,935 8.02 13,038,935 22
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,103,288 2.53 4,103,288 16
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 29,759,101 18.31 29,756,001 186
2] Non Institution
Bodies Corporate 5,121,041 3.15 5,118,841 1,096
Clearing Members 1,703 0.00 1,703 10
Directors of their Relatives 295 0.00 295 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,023,413 1.25 2,018,613 3,919
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,932,358 1.19 1,932,358 3,443
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 11,396,288 7.01 11,396,288 68
Individuals holding nominal share capital up to Rs. 1 lakh 30,924,637 19.03 30,567,341 138,010
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,115 0.00 3,115 7
Others 322,470 0.20 322,470 2
Sub Total 52,967,620 32.60 52,603,324 146,718
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 162,485,569 100.00 162,118,173 146,918

Company Background

Wockhardt LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Wockhardt Ltd
  • BSE Code : 8021.0
  • ISIN : INE049B01025

  • Incorporation Year

    1999

  • Registered Office

    D-4 MIDC
    Chikalthana, Aurangabad.,
    Maharashtra-431006

  • Telephone

    91-240-6694444

  • FAX

    91-240-2489219

  • Chairman

    H F Khorakiwala

  • Managing Director

    Murtaza H Khorakiwala

  • Company Secretary

    Rashmi Mamtura

  • Auditor

    MSKC & Associates LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Wockhardt Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Wockhardt 1,610.40 1,457.00 1,402.00 -2,176.22 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10